| |
| |
|
| Insider
Information: |
Sinclair Michael |
| Relationship: |
Director, 10% Owner |
| City: |
London |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.7
|
| Percentage
Gain/Loss : |
0.0%
|
 512.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Opiant Pharmaceuticals Inc |
OPNT |
Director, 10% Owner |
2023-03-02 |
0 |
2023-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2023-03-02 |
4 |
D |
$20.00 |
$1,254,400 |
D/D |
(62,720) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2023-03-02 |
4 |
D |
$20.00 |
$549,000 |
I/I |
(27,450) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2022-06-15 |
4 |
S |
$10.60 |
$9,540 |
D/D |
(900) |
19,220 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2022-06-14 |
4 |
S |
$10.90 |
$78,753 |
D/D |
(7,225) |
20,120 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2022-06-13 |
4 |
S |
$11.09 |
$60,895 |
D/D |
(5,491) |
27,345 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2022-06-09 |
4 |
S |
$12.25 |
$96,726 |
D/D |
(7,896) |
32,836 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2022-06-07 |
4 |
S |
$12.86 |
$10,288 |
D/D |
(800) |
40,732 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2022-06-06 |
4 |
S |
$12.94 |
$99,483 |
D/D |
(7,688) |
41,532 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2022-06-03 |
4 |
S |
$13.59 |
$139,488 |
D/D |
(10,264) |
49,220 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2022-06-02 |
4 |
S |
$13.88 |
$135,136 |
D/D |
(9,736) |
59,484 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2021-08-25 |
4 |
S |
$14.69 |
$738,452 |
D/D |
(50,269) |
144,070 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2021-08-25 |
4 |
OE |
$5.00 |
$251,345 |
D/D |
50,269 |
194,339 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2021-08-24 |
4 |
S |
$15.71 |
$543,676 |
D/D |
(34,607) |
144,070 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2021-08-24 |
4 |
OE |
$5.00 |
$173,035 |
D/D |
34,607 |
178,677 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2021-08-23 |
4 |
S |
$16.50 |
$1,074,546 |
D/D |
(65,124) |
144,070 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2021-08-23 |
4 |
OE |
$5.00 |
$325,620 |
D/D |
65,124 |
209,194 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
71,220 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2019-09-12 |
4 |
S |
$12.52 |
$751,200 |
D/D |
(60,000) |
69,220 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Executive Chairman |
• • • |
2017-01-17 |
4 |
B |
$7.01 |
$24,518 |
D/D |
3,500 |
132,720 |
3.15 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Executive Chairman |
• • • |
2015-01-21 |
4 |
A |
$3.94 |
$5,910 |
D/D |
1,500 |
80,385 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Executive Chairman |
• • • |
2015-01-21 |
4/A |
A |
$3.94 |
$5,910 |
D/D |
1,500 |
148,870 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Executive Chairman |
• • • |
2015-01-20 |
4/A |
A |
$3.69 |
$5,904 |
D/D |
1,600 |
147,370 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Executive Chairman |
• • • |
2015-01-20 |
4 |
A |
$3.69 |
$5,904 |
D/D |
1,600 |
78,885 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Executive Chairman |
• • • |
2015-01-16 |
4 |
A |
$3.69 |
$6,273 |
D/D |
1,700 |
77,285 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Executive Chairman |
• • • |
2015-01-16 |
4/A |
A |
$3.69 |
$6,273 |
D/D |
1,700 |
145,770 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
